Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Comera Life Sciences Holdings, Inc. (CMRA)
USD0.00
+0.00 (+0.00%)
US OTC Healthcare Biotechnology
Address
12 Gill Street 1801
Woburn, MA, US
Woburn, MA, US
CEO
Michael G. Campbell
Website
comeralifesciences.com
IPO
2020-12-21
CIK 1907685 ISIN US20037C1080
Also trades on
NASDAQ Global Market · CMRAW (USD)
Other OTC · CMRA (USD)
Description
Comera Life Sciences Holdings, Inc. is an early-stage biotechnology firm focused on creating its own pipeline of innovative therapies. These treatments leverage its exclusive SQore formulation platform, engineered to transform intravenous (IV) biologic drugs into more convenient subcutaneous (SQ) injectable forms. Currently, the company is progressing two main product candidates: CLS-001, an early-stage "biobetter" designed to treat inflammatory bowel conditions like Crohn's and Ulcerative Colitis, and CLS-002, another preclinical biobetter aimed at diverse oncology indications. Established in 2014, Comera Life Sciences is headquartered in Woburn, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| OTR | OTRAU | 2022-03-08 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
926
Beta
-20.43
Float Shares
13.53M
Free Float %
44.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +9,900.00% | -50.00% | -99.98% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Quality scores
Altman Z-Score
-28.11
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+98.0% ★ Q3'23: -42.0% (vs Q3'22)
-
EPS growth Biotechnology: +29.7%-506.9% Q3'23: +50.0% (vs Q3'22)
-
FCF margin FCF growth · Biotechnology: +16.2%-2,430.5% Q3'23: -1,404.2% (vs Q3'22)
-
EBIT margin Biotechnology: +0.0%-2,840.6% Q3'23: -1,575.6% (vs Q3'22)
-
ROIC Biotechnology: -16.1%— Q3'23: +147.7% (vs Q3'22)
-
Share dilution Biotechnology: -3.4%-45.2% ★ Q3'23: +44.2% (vs Q3'22)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.04× Q3'23: -0.02× (vs Q3'22)
Valuation Multiples
From
To
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-34.92M
OE per share TTM
-2.04
Owner's Yield
-1,510,683.14%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
93.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
24
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Charles Cherington | 45.99M | 66.31% | 45.99M | — | 45.99M | — | IN | United States | 2024-01-08 | ↗ |
| 2 | David Soane | 10.59M | 26.27% | 10.59M | — | 10.46M | — | IN | United States | 2024-01-08 | ↗ |
| 3 | Curtis Huff | 3.71M | 11.20% | — | 3.71M | — | 3.71M | IN | United States | 2024-01-08 | ↗ |
| 4 | Freebird Investments LLC | 3.71M | 11.20% | — | 3.71M | — | 3.71M | OO | Texas | 2024-01-08 | ↗ |
| 5 | Freebird Partners LP | 3.71M | 11.20% | — | 3.71M | — | 3.71M | PN | Texas | 2024-01-08 | ↗ |
| 6 | The Soane Family Trust | 3.47M | 8.62% | 3.47M | — | 2.81M | — | OO | Florida | 2024-01-08 | ↗ |
| 7 | John D. Halpern | 3.30M | 9.99% | — | 3.30M | — | 3.30M | IN | United States | 2024-01-08 | ↗ |
| 8 | Katherine H. Halpern | 3.30M | 9.99% | — | 3.30M | — | 3.30M | IN | United States | 2024-01-08 | ↗ |
| 9 | IAF, LLC | 3.13M | 9.99% | 3.13M | — | 3.13M | — | OO | South Carolina | 2024-01-08 | ↗ |
| 10 | Phoenix General Partner LLC | 3.05M | 19.20% | 3.05M | — | 3.05M | — | OO | Delaware | 2022-05-31 | ↗ |
| 11 | Phoenix Venture Partners LP | 3.05M | 19.20% | 3.05M | — | 3.05M | — | PN | Delaware | 2022-05-31 | ↗ |
| 12 | Tucker R. Halpern | 1.61M | 4.99% | 1.61M | — | 1.61M | — | IN | United States | 2024-01-08 | ↗ |
| 13 | Warren Street Legacy, LLC | 1.61M | 4.99% | 1.61M | — | 1.61M | — | OO | New York | 2024-01-08 | ↗ |
| 14 | George P. Denny III | 1.56M | 4.99% | 1.56M | — | 1.56M | — | IN | United States | 2024-01-08 | ↗ |
| 15 | Shameek Konar | 1.56M | 4.99% | — | 1.56M | — | 1.56M | IN | United States | 2024-01-08 | ↗ |
| 16 | Victoria Konar | 1.56M | 4.99% | — | 1.56M | — | 1.56M | IN | United States | 2024-01-08 | ↗ |
| 17 | Nicholas J. Singer | 1.45M | 5.17% | 1.45M | — | 1.45M | — | IN | State of Delaware | 2023-08-24 | ↗ |
| 18 | Purchase Capital LLC | 1.45M | 5.17% | — | 1.45M | — | 1.45M | OO | State of Delaware | 2023-08-24 | ↗ |
| 19 | Huff | 1.31M | 5.71% | — | 1.31M | — | 1.31M | IN | Texas | 2023-01-10 | ↗ |
| 20 | Investments LLC | 1.31M | 5.71% | — | 1.31M | — | 1.31M | OO | Texas | 2023-01-10 | ↗ |
| 21 | LP | 1.31M | 5.71% | — | 1.31M | — | 1.31M | PN | Texas | 2023-01-10 | ↗ |
| 22 | Stephen E. Older | 1.17M | 3.69% | 1.17M | — | 1.17M | — | IN | United States | 2024-01-08 | ↗ |
| 23 | 2 | 967.5K | 5.90% | 967.5K | — | 967.5K | — | IN | New York | 2022-06-03 | ↗ |
| 24 | OTR Acquisition Sponsor LLC | 796.2K | 2.90% | 796.2K | — | 796.2K | — | OO | Delaware | 2023-08-16 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
7
Sells
0
Shares acquired
357.0K
Shares disposed
—
Cash buys
1.00
Cash sales
—
Net activity
+356,998
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-29 | Warren Street Legacy, LLC | — | — | D | 12.0% Senior Secured Convertible Notes | 681,818 | 0.06 | 37.5K | 0 | — | ↗ |
| 2023-12-29 | Soane David | 10% Owner | P-Purchase | A | Warrant (right to buy) | 2,727,272 | 0.06 | 150.0K | 2,727,272 | — | ↗ |
| 2023-12-29 | Konar Shameek | 10% Owner | P-Purchase | A | Warrants to Purchase Common Stock | 4,090,908 | 0.06 | 225.0K | 4,090,908 | — | ↗ |
| 2023-12-29 | IAF, LLC | — | P-Purchase | A | 12.0% Senior Secured Convertible Notes | 0 | 0.06 | — | 0 | — | ↗ |
| 2023-12-29 | Halpern Tucker R. | — | — | I | 12.0% Senior Secured Convertible Notes | 545,454 | 0.06 | 30.0K | 0 | — | ↗ |
| 2023-12-29 | HALPERN JOHN D | — | — | I | 12.0% Senior Secured Convertible Notes | 2,036,872 | 0.06 | 112.0K | 0 | — | ↗ |
| 2023-12-29 | Freebird Partners LP | 10% Owner | P-Purchase | A | Convertible Note Shares | 2,453,636 | 0.06 | 134.9K | 2,453,636 | — | ↗ |
| 2023-12-29 | DENNY GEORGE P III | — | P-Purchase | A | Warrants to Purchase Common Stock | 3,913,526 | 0.06 | 215.2K | 3,913,526 | — | ↗ |
| 2023-12-29 | Cherington Charles | 10% Owner | P-Purchase | A | 12.0% Senior Secured Convertible Notes | 0 | 0.06 | — | 0 | — | ↗ |
| 2023-12-27 | Warren Street Legacy, LLC | — | — | D | Common Stock | 0 | 0.00 | — | 195,598 | — | ↗ |
| 2023-12-27 | Konar Shameek | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,001,064 | — | ↗ |
| 2023-12-27 | IAF, LLC | — | — | D | Common Stock | 0 | 0.00 | — | 2,506,914 | — | ↗ |
| 2023-12-27 | Halpern Tucker R. | — | — | I | Common Stock | 0 | 0.00 | — | 146,698 | — | ↗ |
| 2023-12-27 | HALPERN JOHN D | — | — | I | Common Stock | 0 | 0.00 | — | 1,088,819 | — | ↗ |
| 2023-12-27 | DENNY GEORGE P III | — | — | I | Common Stock | 0 | 0.00 | — | 969,049 | — | ↗ |
| 2023-12-27 | Cherington Charles | 10% Owner | P-Purchase | A | Series A Convertible Perpetual Preferred Stock | 3,896 | 12.56 | 48.9K | 3,896 | — | ↗ |
| 2023-12-03 | Freebird Partners LP | 10% Owner | — | D | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 1,254,776 | — | ↗ |
| 2023-11-27 | Campbell Michael Gerard | Officer | P-Purchase | A | Common Stock | 10,000 | 0.07 | 708.00 | 35,000 | — | ↗ |
| 2023-11-15 | Wexler William A. | Director | J-Other | A | Common Stock | 3,113 | 0.00 | — | 20,811 | — | ↗ |
| 2023-11-09 | Sullivan Edward Aloysius Jr. | Director | A-Award | A | Stock Option (Right to Purchase) | 127,198 | 0.32 | 40.8K | 127,198 | — | ↗ |
| 2023-11-09 | FLOWERS KIRSTEN | Director | A-Award | A | Stock Option (Right to Purchase) | 111,494 | 0.32 | 35.7K | 111,494 | — | ↗ |
| 2023-11-09 | Banerjee Sirshendu Roopom | Director | A-Award | A | Stock Option (Right to Purchase) | 122,487 | 0.32 | 39.2K | 122,487 | — | ↗ |
| 2023-11-07 | Clarke Dorothy J | Director | A-Award | A | Stock Option (Right to Purchase | 14,200 | 0.36 | 5.0K | 14,200 | — | ↗ |
| 2023-10-14 | Muni Neal | Officer | A-Award | A | Stock Option (Right to Purchase) | 60,000 | 0.29 | 17.4K | 60,000 | — | ↗ |
| 2023-10-14 | McCourt Janice | Officer | A-Award | A | Stock Option (Right to Purchase) | 20,000 | 0.29 | 5.8K | 20,000 | — | ↗ |
| 2023-09-27 | Mahoney Robert Patrick | Officer | A-Award | A | Stock Option (Right to Purchase) | 300,000 | 0.38 | 112.8K | 300,000 | — | ↗ |
| 2023-09-27 | Hackman Jeffrey S. | Director / Officer | A-Award | A | Stock Option (Right to Purchase) | 600,000 | 0.38 | 225.6K | 600,000 | — | ↗ |
| 2023-09-27 | Campbell Michael Gerard | Officer | A-Award | A | Stock Option (Right to Purchase) | 350,000 | 0.38 | 131.6K | 350,000 | — | ↗ |
| 2023-09-11 | Warren Street Legacy, LLC | — | — | D | Warrants to Purchase Common Stock | 146,699 | 0.61 | 90.0K | 0 | — | ↗ |
| 2023-09-11 | Soane David | 10% Owner | P-Purchase | A | Common Stock | 58,680 | 0.51 | 30.0K | 284,328 | — | ↗ |
| 2023-09-11 | Konar Shameek | 10% Owner | — | I | Warrants to Purchase Common Stock | 513,447 | 0.61 | 315.0K | 0 | — | ↗ |
| 2023-09-11 | IAF, LLC | — | — | D | Warrants to Purchase Common Stock | 1,122,249 | 0.61 | 688.5K | 0 | — | ↗ |
| 2023-09-11 | Halpern Tucker R. | — | — | I | Warrants to Purchase Common Stock | 110,024 | 0.61 | 67.5K | 0 | — | ↗ |
| 2023-09-11 | HALPERN JOHN D | — | — | I | Warrants to Purchase Common Stock | 366,748 | 0.61 | 225.0K | 0 | — | ↗ |
| 2023-09-11 | Freebird Partners LP | 10% Owner | — | D | Common Stock Purchase Warrant | 513,447 | 0.61 | 315.0K | 0 | — | ↗ |
| 2023-09-11 | DENNY GEORGE P III | — | — | I | Warrants to Purchase Common Stock | 337,408 | 0.61 | 207.0K | 0 | — | ↗ |
| 2023-09-11 | Cherington Charles | 10% Owner | P-Purchase | A | Common Stock | 2,053,789 | 0.51 | 1.05M | 5,813,650 | — | ↗ |
| 2023-08-31 | Wexler William A. | Director | A-Award | A | Stock Option (Right to Purchase) | 46,728 | 0.70 | 32.7K | 46,728 | — | ↗ |
| 2023-08-31 | Sullivan Edward Aloysius Jr. | Director | A-Award | A | Stock Option (Right to Purchase) | 75,934 | 0.70 | 53.1K | 75,934 | — | ↗ |
| 2023-08-31 | Sherblom James | Director | A-Award | A | Stock Option (Right to Purchase) | 52,570 | 0.70 | 36.8K | 52,570 | — | ↗ |
| 2023-08-31 | RANDLE STUART A | Director | A-Award | A | Stock Option (Right to Purchase) | 96,378 | 0.70 | 67.4K | 96,378 | — | ↗ |
| 2023-08-31 | FLOWERS KIRSTEN | Director | A-Award | A | Stock Option (Right to Purchase) | 67,172 | 0.70 | 47.0K | 67,172 | — | ↗ |
| 2023-08-31 | Banerjee Sirshendu Roopom | Director | A-Award | A | Stock Option (Right to Purchase) | 75,934 | 0.70 | 53.1K | 75,934 | — | ↗ |
| 2023-08-14 | Mahoney Robert Patrick | Officer | P-Purchase | A | Common Stock | 20,000 | 0.63 | 12.5K | 124,576 | — | ↗ |
| 2023-08-11 | Wexler William A. | Director | J-Other | A | Common Stock | 6,636 | 0.00 | — | 17,698 | — | ↗ |
| 2023-07-31 | Soane David | 10% Owner | P-Purchase | A | Warrant (right to buy) | 342,298 | 0.61 | 210.0K | 342,298 | — | ↗ |
| 2023-07-31 | Cherington Charles | 10% Owner | P-Purchase | A | Common Stock | 880,195 | 0.51 | 450.0K | 3,759,861 | — | ↗ |
| 2023-05-12 | Wexler William A. | Director | A-Award | A | Stock Option (Right to Purchase) | 27,472 | 0.69 | 19.0K | 27,472 | — | ↗ |
| 2023-05-12 | Sullivan Edward Aloysius Jr. | Director | A-Award | A | Stock Option (Right to Purchase) | 44,642 | 0.69 | 30.8K | 44,642 | — | ↗ |
| 2023-05-12 | Sherblom James | Director | A-Award | A | Stock Option (Right to Purchase) | 30,906 | 0.69 | 21.3K | 30,906 | — | ↗ |
| 2023-05-12 | RANDLE STUART A | Director | A-Award | A | Stock Option (Right to Purchase) | 56,662 | 0.69 | 39.1K | 56,662 | — | ↗ |
| 2023-05-12 | FLOWERS KIRSTEN | Director | A-Award | A | Stock Option (Right to Purchase) | 39,491 | 0.69 | 27.2K | 39,491 | — | ↗ |
| 2023-05-12 | Banerjee Sirshendu Roopom | Director | A-Award | A | Stock Option (Right to Purchase) | 44,642 | 0.69 | 30.8K | 44,642 | — | ↗ |
| 2023-02-14 | Wexler William A. | Director | A-Award | A | Stock Option (Right to Purchase) | 7,100 | 1.30 | 9.2K | 7,100 | — | ↗ |
| 2023-02-14 | Sullivan Edward Aloysius Jr. | Director | A-Award | A | Stock Option (Right to Purchase) | 7,100 | 1.30 | 9.2K | 7,100 | — | ↗ |
| 2023-02-14 | Sherblom James | Director | A-Award | A | Stock Option (Right to Purchase) | 7,100 | 1.30 | 9.2K | 7,100 | — | ↗ |
| 2023-02-14 | RANDLE STUART A | Director | A-Award | A | Stock Option (Right to Purchase) | 7,100 | 1.30 | 9.2K | 7,100 | — | ↗ |
| 2023-02-14 | Muni Neal | Officer | A-Award | A | Stock Option (Right to Purchase) | 100,000 | 1.30 | 130.0K | 100,000 | — | ↗ |
| 2023-02-14 | Mahoney Robert Patrick | Officer | A-Award | A | Stock Option (Right to Purchase) | 25,000 | 1.30 | 32.5K | 25,000 | — | ↗ |
| 2023-02-14 | Hackman Jeffrey S. | Director / Officer | A-Award | A | Stock Option (Right to Purchase) | 100,000 | 1.30 | 130.0K | 100,000 | — | ↗ |
| 2023-02-14 | FLOWERS KIRSTEN | Director | A-Award | A | Stock Option (Right to Purchase) | 7,100 | 1.30 | 9.2K | 7,100 | — | ↗ |
| 2023-02-14 | Campbell Michael Gerard | Officer | A-Award | A | Stock Option (Right to Purchase) | 25,000 | 1.30 | 32.5K | 25,000 | — | ↗ |
| 2023-02-14 | Banerjee Sirshendu Roopom | Director | A-Award | A | Stock Option (Right to Purchase) | 7,100 | 1.30 | 9.2K | 7,100 | — | ↗ |
| 2023-01-04 | Sullivan Edward Aloysius Jr. | Director | A-Award | A | Warrants (right to buy) | 10,979 | 0.25 | 2.7K | 10,979 | — | ↗ |
| 2023-01-04 | Soane David | Director | P-Purchase | A | Common Stock | 67,567 | 1.23 | 83.1K | 3,336,562 | — | ↗ |
| 2023-01-04 | Sherblom James | Director | P-Purchase | A | Common Stock | 81,081 | 1.23 | 99.7K | 452,244 | — | ↗ |
| 2023-01-04 | RANDLE STUART A | Director | P-Purchase | A | Common Stock | 33,783 | 1.23 | 41.6K | 42,469 | — | ↗ |
| 2023-01-04 | IAF, LLC | — | — | D | Warrants to Purchase Common Stock | 1,033,782 | 1.23 | 1.27M | 0 | — | ↗ |
| 2023-01-04 | Freebird Partners LP | 10% Owner | — | D | Common Stock Purchase Warrant | 743,242 | 1.23 | 914.2K | 0 | — | ↗ |
| 2023-01-04 | FLOWERS KIRSTEN | Director | A-Award | A | Common Stock | 13,513 | 1.23 | 16.6K | 22,199 | — | ↗ |
| 2023-01-04 | FINCK BARBARA K | Director | A-Award | A | Warrants (right to buy) | 6,756 | 0.25 | 1.7K | 6,756 | — | ↗ |
| 2023-01-04 | DENNY GEORGE P III | — | — | I | Warrants to Purchase Common Stock | 405,405 | 1.23 | 498.6K | 0 | — | ↗ |
| 2023-01-04 | Cherington Charles | Director | P-Purchase | A | Common Stock | 743,243 | 1.23 | 914.2K | 2,879,666 | — | ↗ |
| 2023-01-04 | Banerjee Sirshendu Roopom | Director | A-Award | A | Warrants (right to buy) | 20,270 | 0.25 | 5.1K | 20,270 | — | ↗ |
| 2023-01-02 | HALPERN JOHN D | — | — | I | Warrants to Purchase Common Stock | 405,404 | 1.23 | 498.6K | 0 | — | ↗ |
| 2022-11-08 | Soane David | Director | P-Purchase | A | Common Stock | 3,000 | 1.38 | 4.1K | 3,268,995 | — | ↗ |
| 2022-11-08 | McCourt Janice | Officer | A-Award | A | Stock Option (Right to Purchase) | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2022-11-01 | McCourt Janice | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-10-21 | Cherington Charles | Director | P-Purchase | A | Common Stock | 11,691 | 1.59 | 18.6K | 649,937 | — | ↗ |
| 2022-10-20 | Cherington Charles | Director | P-Purchase | A | Common Stock | 3,316 | 1.52 | 5.0K | 638,246 | — | ↗ |
| 2022-10-17 | Cherington Charles | Director | P-Purchase | A | Common Stock | 15,266 | 1.66 | 25.3K | 634,930 | — | ↗ |
| 2022-10-14 | Cherington Charles | Director | P-Purchase | A | Common Stock | 4,253 | 1.60 | 6.8K | 619,664 | — | ↗ |
| 2022-10-13 | Cherington Charles | Director | P-Purchase | A | Common Stock | 10,481 | 1.66 | 17.4K | 615,411 | — | ↗ |
| 2022-09-29 | Cherington Charles | Director | P-Purchase | A | Common Stock | 17,900 | 1.87 | 33.5K | 604,930 | — | ↗ |
| 2022-09-27 | Cherington Charles | 10% Owner | P-Purchase | A | Common Stock | 12,000 | 1.69 | 20.2K | 587,030 | — | ↗ |
| 2022-09-16 | Muni Neal | Officer | — | D | Stock Option (Right to Buy) | 208,199 | 0.77 | 160.3K | 0 | — | ↗ |
| 2022-09-16 | Mahoney Robert Patrick | Officer | — | D | Stock Option (Right to Buy) | 25,490 | 0.77 | 19.6K | 0 | — | ↗ |
| 2022-09-16 | Hackman Jeffrey S. | Director / Officer | — | D | Stock Option (Right to Buy) | 277,599 | 0.77 | 213.8K | 0 | — | ↗ |
| 2022-09-12 | Sherblom James | Director | P-Purchase | A | Common Stock | 50,000 | 2.03 | 101.5K | 371,163 | — | ↗ |
| 2022-09-09 | Hackman Jeffrey S. | Director / Officer | P-Purchase | A | Common Stock | 47,600 | 2.06 | 98.1K | 47,600 | — | ↗ |
| 2022-09-08 | Campbell Michael Gerard | Officer | P-Purchase | A | Common Stock | 25,000 | 2.07 | 51.8K | 25,000 | — | ↗ |
| 2022-08-09 | Wexler William A. | Director | A-Award | A | Stock Option (Right to Purchase) | 14,200 | 0.00 | — | 14,200 | — | ↗ |
| 2022-08-09 | Muni Neal | Officer | A-Award | A | Stock Option (Right to Purchase) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-08-09 | Hackman Jeffrey S. | Officer | A-Award | A | Stock Option (Right to Purchase) | 300,000 | 0.00 | — | 300,000 | — | ↗ |
| 2022-06-18 | Wexler William A. | Director | — | D | Warrants (right to buy) | 50,000 | 11.50 | 575.0K | 0 | — | ↗ |
| 2022-06-15 | Campbell Michael Gerard | Officer | A-Award | A | Stock Option (Right to Purchase) | 450,000 | 0.00 | — | 450,000 | — | ↗ |
| 2022-05-19 | Yee John D. | Director | — | D | Common Stock | 0 | 0.00 | — | 11,968 | — | ↗ |
| 2022-05-19 | Wexler William A. | Director | — | D | Common Stock | 0 | 0.00 | — | 11,062 | — | ↗ |
| 2022-05-19 | Sullivan Edward Aloysius Jr. | Director | A-Award | A | Stock Option (Right to Buy) | 44,981 | 0.59 | 26.5K | 44,981 | — | ↗ |
| 2022-05-19 | Soane David | Director | — | I | Common Stock | 0 | 0.00 | — | 3,265,995 | — | ↗ |
| 2022-05-19 | Sherblom James | Director | — | D | Common Stock | 0 | 0.00 | — | 321,163 | — | ↗ |
| 2022-05-19 | RANDLE STUART A | Director | — | D | Earn-Out Shares | 2,213 | 0.00 | — | 0 | — | ↗ |
| 2022-05-19 | Phoenix Venture Partners LP | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 3,052,835 | — | ↗ |
| 2022-05-19 | Muni Neal | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-05-19 | Mahoney Robert Patrick | Officer | — | D | Earn-Out Shares | 26,651 | 0.00 | — | 0 | — | ↗ |
| 2022-05-19 | Hackman Jeffrey S. | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-05-19 | FLOWERS KIRSTEN | Director | — | D | Common Stock | 0 | 0.00 | — | 8,686 | — | ↗ |
| 2022-05-19 | FINCK BARBARA K | Director | — | D | Common Stock | 0 | 0.00 | — | 16,277 | — | ↗ |
| 2022-05-19 | Campbell Michael Gerard | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-05-19 | Banerjee Sirshendu Roopom | Director | A-Award | A | Stock Option (Right to Buy) | 44,981 | 0.59 | 26.5K | 44,981 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-15.0K
Shares Outstanding
30.74M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2022 | Michael G. Campbell, Chief Financial Officer | 201.9K | — | — | 954.9K | — | — | 1.16M | 82.55% | ↗ |
| 2 | 2022 | Jeffrey S. Hackman, Chief Executive Officer | 400.0K | — | — | 535.2K | — | — | 935.2K | 57.23% | ↗ |
| 3 | 2022 | Neal Muni, MD, Chief Operating Officer | 350.0K | — | — | 89.2K | — | — | 439.2K | 20.31% | ↗ |
| 4 | 2021 | Jeffrey S. Hackman, Chief Executive Officer | 132.5K | 51.1K | — | 161.6K | — | — | 345.2K | 46.82% | ↗ |
| 5 | 2021 | Neal Muni, MD, Chief Operating Officer | 106.2K | 46.0K | — | 121.2K | — | — | 273.4K | 44.34% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael G. Campbell | Chief Executive Officer, Chief Financial Officer & Principal Accounting Officer | 269.1K | male |
| David Soane | Co-Founder & Member of Scientific Advisory Board | — | — |
| Janice Marie McCourt | Chief Business Officer | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CMRA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
